MAYNE PHARMA GROUP LTD

3.210

+0.0300.94%

Volume:9K

Turnover:29.42K

Market Cap:260.80M

PE:-3.05

High:3.210

Open:3.210

Low:3.180

Close:3.180

52wk High:6.500

52wk Low:2.040

Shares:81.25M

Float Shares:67.00M

Volume Ratio:0.35

T/O Rate:0.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.051

EPS(LYR):-1.186

ROE:-20.58%

ROA:-2.30%

PB:0.74

PE(LYR):-2.71

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+1.46%

Capital Flow

Inflow:

Outflow:

News

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/stock/MYX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MYX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","market":"AU","secType":"STK","nameCN":"MAYNE PHARMA GROUP LTD","latestPrice":3.21,"timestamp":1787618783514,"preClose":3.18,"halted":0,"volume":9214,"delay":0,"changeRate":0.009433962264150882,"nameEN":"MAYNE PHARMA GROUP LTD","floatShares":66997185,"shares":81245827,"eps":-1.051059,"marketStatus":"Trading","change":0.03,"latestTime":"08-25 10:47:16 AEST","open":3.21,"high":3.21,"low":3.18,"amount":29422,"amplitude":0.009434,"askPrice":3.21,"askSize":149,"bidPrice":3.2,"bidSize":2908,"shortable":3,"etf":0,"ttmEps":-1.051059,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787637600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":3.18,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":0.352712,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MYX.AU","preClose":3.26,"auctionPrice":3.19,"auctionVolume":1629,"auction":3,"marketStatus":"盘后竞价","timestamp":1787551803275}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","floatShares":66997185,"roa":"-2.30%","roe":"-20.58%","lyrEps":-1.185711,"volumeRatio":0.352712,"shares":81245827,"dividePrice":0,"high":3.21,"amplitude":0.009434,"preClose":3.18,"low":3.18,"week52Low":2.04,"pbRate":"0.74","psRate":"0.64","week52High":6.5,"institutionHeld":0,"latestPrice":3.21,"committee":0.902519,"eps":-1.051059,"divideRate":0,"volume":9214,"delay":0,"ttmEps":-1.051059,"open":3.21,"prevYearClose":3.11,"prevWeekClose":3.26,"prevMonthClose":2.66,"prevQuarterClose":2.79,"fiveDayClose":3.23,"twentyDayClose":2.62,"sixtyDayClose":2.33,"earningDate":1787760000000,"dividendPayoutRate":0.04569711225089115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.014818181818181815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787788800000,"name":null,"time":"","dateTimestamp":1787752800000,"actualEps":null},{"date":"2026-02-22","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771714800000,"name":null,"time":"","dateTimestamp":1771678800000,"actualEps":null},{"date":"2025-08-29","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756425600000,"name":null,"time":"","dateTimestamp":1756389600000,"actualEps":null},{"date":"2025-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-23","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724371200000,"name":null,"time":"","dateTimestamp":1724335200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYX.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-01-18","recordDate":"2023-01-19","paymentDate":"2023-01-27","value":0.038,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MYX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660794482","title":"Inhibitor Therapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2660794482","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660794482?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:02","pubTimestamp":1786968142,"startTime":"0","endTime":"0","summary":"Inhibitor Therapeutics announces annual shareholder meetingInhibitor Therapeutics schedules a virtual annual stockholder meeting on Sept. 15, 2026, held via the internet.Items include election of six ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDLBW5kx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","INTI","MYX.AU","BK7096","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657594604","title":"Mayne Pharma Group Ltd-Non-Executive Director Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2657594604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657594604?lang=en_us&edition=fundamental","pubTime":"2026-08-05 11:35","pubTimestamp":1785900920,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUE2LT2TP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7508","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656581918","title":"3 ASX Penny Stocks With Market Caps Under A$2B","url":"https://stock-news.laohu8.com/highlight/detail?id=2656581918","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656581918?lang=en_us&edition=fundamental","pubTime":"2026-08-04 10:08","pubTimestamp":1785809324,"startTime":"0","endTime":"0","summary":"Australian shares are poised for a modest gain today, buoyed by a positive surge in U.S. equities, particularly from strong tech sector performances. For those looking beyond the major players, penny stocks—often smaller or newer companies—remain an intriguing area of investment despite being considered somewhat outdated as a term. In this article, we explore three penny stocks that combine robust financials with potential for significant growth, offering investors the chance to uncover...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/diversified-financials/asx-rpl/regal-partners-shares/news/3-asx-penny-stocks-with-market-caps-under-a2b-5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/diversified-financials/asx-rpl/regal-partners-shares/news/3-asx-penny-stocks-with-market-caps-under-a2b-5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7096","MYX.AU","SSM.AU","BK7508","RPL.AU","BK7062","BK7055"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655335608","title":"Australia's Mayne Pharma Falls on Lower Unaudited Revenue and Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2655335608","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655335608?lang=en_us&edition=fundamental","pubTime":"2026-07-31 10:56","pubTimestamp":1785466577,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mayne Pharma falls on lower unaudited revenue and earnings** Shares of Australia's Mayne Pharma GroupMYX.AXfall as much as 7.1% to A$2.415, marking their biggest intraday pct loss since March 19** Shares hit their lowest level since June 26** Specialty pharmaceutical copostsunaudited 4Q FY26 underlying EBITDA of A$4.6 million , down 76% from A$19.3 million last year** Posts unaudited 4Q FY26 revenue of A$86.5 million, down 22% from A$110.7 million in 4Q 2025** Co expects FY26 revenue to be A$383.7 million and underlying EBITDA to be A$31.7 million, down 6% and 33% on pcp, respectively** Nearly 259,300 shares change hands, about 1.3x the 30-day average** Stock down 19.3% YTD, including session's moves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL4N43X09H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":13,"pageCount":1,"totalSize":52,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MYX.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.014628}]}}